Also trades as: INDV.L (LSE) · $vol 5M
INDV NASDAQ
Indivior Pharmaceuticals Inc
1W: -0.1%
1M: -5.9%
3M: -13.4%
YTD: -2.8%
1Y: +38.2%
3Y: +86.7%
5Y: +115.7%
$34.72
+0.16 (+0.46%)
After Hours: $36.79 (+2.07, +5.96%)
Weekly Expected Move ±4.8%
$31
$33
$34
$36
$38
Credit Risk of going bust: lower than 74% of companies Debt: 10.6% of company value Bonds: $90.4M held by 58 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.31 (down 99.1%), Indivior Pharmaceuticals Inc would be worth roughly what it owes.
Total debt $509.0M against a stock market value of $4.31B.
Distance to default 8.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $252.5M (short-term plus half of long-term), stock volatility 36.3%; Altman Z 3.48. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.31 (down 99.1%), Indivior Pharmaceuticals Inc would be worth roughly what it owes.
Total debt $509.0M against a stock market value of $4.31B.
Distance to default 8.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $252.5M (short-term plus half of long-term), stock volatility 36.3%; Altman Z 3.48. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.3B
52W Range24.28-42.81
Volume2,077,506
Avg Volume2,189,022
Beta1.11
Dividend—
Analyst Ratings
Company Info
CEOJoseph J. Ciaffoni
Employees833
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-12-29
Websiteindivior.com
10710 Midlothian Turnpike
North Chesterfield, VA 23235
US
North Chesterfield, VA 23235
US
804 379 1090
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Latest News
MSG Rangers and Huron Consulting Group to join S&P SmallCap 600
1,999,416 Indivior PLC $INDV Shares Acquired by Assenagon Asset Management S.A.
Indivior PLC $INDV Stock Bought by Artemis Investment Management LLP
These healthcare stocks stand out with A+ growth grades
Here's Why Indivior Pharmaceuticals Inc. (INDV) is a Strong Growth Stock
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Anderson Woodrow D | P-Purchase | 1,500 | $35.69 | 2026-08-27 |
| Anderson Woodrow D | P-Purchase | 1,500 | $36.28 | 2026-08-05 |
| Heidbreder Christian | S-Sale | 18,586 | $41.14 | 2026-07-10 |
| Ciaffoni Joseph | M-Exempt | 1,266,903 | — | 2026-06-22 |
| Ciaffoni Joseph | F-InKind | 612,549 | $38.32 | 2026-06-22 |